Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2008-04-01
2008-04-01
Canella, Karen A. (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C436S064000, C436S094000
Reexamination Certificate
active
10326483
ABSTRACT:
The present invention provides a method for detection of loss of heterozygosity (LOH) at human chromosome segment 11p15.5 in a tumor sample from a patient with non-small-cell lung cancer (NSCLC), and a method for prognosis of the patient's disease progression. The prognosis is useful for determining the course of treatment following surgical resection of tumor.
REFERENCES:
patent: 6183954 (2001-02-01), Bar-Shavit
Kim et al (Int Journal of Cancer, 2000, vol. 87, pp. 61-67).
Abstract of Fong et al (Genes, Chromsomes and Cancer, 1994, vol. 10, pp. 183-189).
Rosell et al (Current Opinion in Oncology, Mar. 2001, vol. 13, pp. 101-109.
Ginsberg et al, ‘Non-Small Cell Lung Cancer’, In: Cancer: Principles and Practice of Oncology, 1997, DeVita et al, Ed.s, pp. 877 and 888.
Fong et al (Genes, Chromosomes and Cancer, 1994, vol. 10, pp. 183-189).
MOUNTAIN,Revisions in the International System for Staging Lung Cancer, CHEST The Cardiopulmonary and Critical Care Journal, pp. 1710-1717, downloaded from www.chestjournal.org by on Feb. 21, 2006.
Bepler et al.,Three Tumor-Suppressor Regions on Chromosome 11p Identified by High-Resolution Deletion Mapping in Human Non-Small-Cell Lung Cancer, Proc. Natl. Acad. Sci., USA, Jun. 1994, vol. 91. pp. 5513-5517.
Bepler et al.,A 1.4-Mb High-Resolution Physical Map and Contig of Chromosome Segment 11p15.5 and Genes in the LOH11A Metastasis Suppressor Region, Genomics, 1999, vol. 55, pp. 164-175.
Cavenee et al.,Expression of Recessive Alleles by Chromosomal Mechanisms in Retinoblastoma, Nature, 1983, vol. 305, pp. 779-784.
Fong et al.,Tumor Progression and Loss of Heterozygosity at 5q and 18q in Non-Small Cell Lung Cancer, Cancer Research, Jan. 15, 1995, vol. 55, pp. 220-223.
Pitterle et al.,Lung Cancer and the Human Gene for Ribonucleotide Reductase Subunit M1(RRM1), Mammalian Genome, 1999, vol. 10, pp. 916-922.
Tran et al.,High-Density Marker Analysis of 11p15.5 in Non-Small Cell Lung Carcinomas Reveals Allelic Deletion of One Shared and One Distinct Region When Compared to Breast Carcinomas, Cancer Research, Jul. 1, 1996, vol. 56, pp. 2916-2921.
Weston et al.,Differential DNA Sequence Deletions from Chromosomes 3, 11, 13, and 17 in Squamous-Cell Carcinoma, Large-Cell Carcinoma, and Adenocarcinoma of the Human Lung, Proc. Natl. Acad. Sci, USA, Jul. 1989, vol. 86, pp. 5099-5103.
Zhao et al.,Transcript Map and Complete Genomic Sequence for the 310 kb Region of Minimal Allele Loss on Chromosome Segment 11p15.5 in Non-Small-Cell Lung Cancer, Oncogene, 2001, vol. 20, pp. 8154-8164.
Canella Karen A.
Health Research , Inc.
Hodgson & Russ LLP
LandOfFree
Prognostic significance of molecular genetic aberrations on... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prognostic significance of molecular genetic aberrations on..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prognostic significance of molecular genetic aberrations on... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3941641